Hepatitis C virus and essential mixed cryoglobulinaemia

Area of Science:

• Immunology
• Hepatology
• Virology

Background:

• Essential mixed cryoglobulinaemia (EMC) often presents with clinical and laboratory signs of liver damage.
• The association between EMC and specific viral infections requires further elucidation.

Purpose of the Study:

• To investigate the prevalence of hepatitis C virus (HCV) infection in patients diagnosed with essential mixed cryoglobulinaemia (EMC).
• To compare clinical, biological, and histological characteristics between HCV-positive and HCV-negative EMC patients.

Main Methods:

• Utilized ELISA 2 and RIBA 2 tests to detect anti-HCV antibodies in 37 EMC patients.
• Compared 16 anti-HCV antibody-positive patients (Group 1) with 21 anti-HCV antibody-negative patients (Group 2).
• Assessed serum hepatitis B virus (HBV) markers and HBV DNA levels.

Main Results:

• 43% (16/37) of EMC patients tested positive for anti-HCV antibodies.
• HCV-positive patients exhibited significantly more frequent cutaneous involvement (P = 0.02).
• Group 1 showed increased clinical, biological, and histological hepatic involvement (P < 0.01), higher serum cryoglobulin levels, and lower CH50 levels (P < 0.001) compared to Group 2.
• Hepatitis B virus markers were uncommon, with no detectable HBV DNA in either group.

Conclusions:

• Hepatitis C virus infection is a potential causative agent of essential mixed cryoglobulinaemia.
• HCV infection in EMC is associated with specific clinical and laboratory findings, including hepatic and cutaneous manifestations.
• Further research is warranted to confirm the etiological role of HCV in EMC.